CANbridge Pharmaceuticals Inc. (HKG:1228)

Hong Kong · Delayed Price · Currency is HKD

2.720

-0.020 (-0.73%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Development, Production, Marketing and Sale of Medical Products	85.10M	102.87M	78.97M	31.16M	12.03M
Development, Production, Marketing and Sale of Medical Products Growth	-17.27%	30.26%	153.43%	158.98%	719.06%
Total	85.10M	102.87M	78.97M	31.16M	12.03M
Total Growth	-17.27%	30.26%	153.43%	158.98%	719.06%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Chinese Mainland	40.97M	55.87M	31.49M	7.35M	5.45M
Chinese Mainland Growth	-26.67%	77.43%	328.27%	34.97%	413.48%
Other Countries/Regions	44.13M	47.00M	47.48M	23.81M	6.58M
Other Countries/Regions Growth	-6.10%	-1.02%	99.43%	261.60%	-
Total	85.10M	102.87M	78.97M	31.16M	12.03M
Total Growth	-17.27%	30.26%	153.43%	158.98%	719.06%

Source: S&P Global Market Intelligence.